Updates are available Correction dated 2024-01-11
Click to view Correction: https://doi.org/10.1007/s10719-024-10146-x
-
Authors
Šimunić-Briški, Nina
Dukarić, Vedran
Očić, Mateja
Madžar, Tomislav
Vinicki, Martina
Frkatović-Hodžić, Azra
Knjaz, Damir
Lauc, Gordan
-
Funding
Funding for this research was provided by:
European Structural and Investment Fund, Croatian National Centre of Competence in Molecular Diagnostics (KK.01.2.2.03.0006, KK.01.2.2.03.0006, KK.01.2.2.03.0006, KK.01.2.2.03.0006, KK.01.2.2.03.0006, KK.01.2.2.03.0006, KK.01.2.2.03.0006, KK.01.2.2.03.0006)
European Research Council ERC-Synergy Grant „GlycanSwitch “ (#101071386, #101071386, #101071386, #101071386, #101071386, #101071386, #101071386, #101071386)
- License Information
-
More Information
Article History
Received: 6 December 2023
Revised: 6 December 2023
Accepted: 13 December 2023
First Online: 26 December 2023
Change Date: 11 January 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s10719-024-10146-x
Declarations
:
: The study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board (or Ethics Committee) of the Faculty of Kinesiology, University of Zagreb (31/2017) and Ethics Committee of School of Medicine, University of Zagreb (380-59-10106-18-111/110).
: G. Lauc is the founder and owner of Genos Ltd, a private research organization that specializes in high throughput glycomic analyses and has several patents in this field. N. Šimunić-Briški, M. Vinicki and A. Frkatović-Hodžić are employees of Genos Ltd. G. Lauc is also co-founder of GlycanAge Ltd and is listed as an inventor on patents EP3011335B1 and US9910046B2 that protect the use of GlycanAge® to predict biological age. All other authors declare no conflicts of interest.
